There are several ongoing immunotherapies for lung cancer including Programmed cell death protein 1 (PD-1) inhibitors, Programmed death-ligand 1 (PD-L1) inhibitors, Chimeric antigen receptor (CAR) T-cell therapy, Oncolytic viruses, and Cancer vaccines. The gene discussed is CD274; the disease is lung carcinoma.